Status:
COMPLETED
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Squamous Cell Carcinoma
Eligibility:
All Genders
26-85 years
Brief Summary
Recent studies have shown that dysregulation of ANXA1 expression are associated with tumorigenesis. Overexpression of ANXA1 protein is found in a wide variety of human tumors, such as breast 10, liver...
Detailed Description
MATERIAL AND METHODS After approval by the Hospital Review Board, we obtained formalin-fixed, paraffin-embedded specimens from 115 patients with primary oral SCC and 66 patients with oral ED at the D...
Eligibility Criteria
Inclusion
- noraml, dysplasia, SCC
Exclusion
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00364715
Start Date
January 1 2005
End Date
December 1 2005
Last Update
August 17 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100